CC100: Phase 1 Multiple-Dose Safety and Tolerability in Subjects With ALS
Condition: Amyotrophic Lateral Sclerosis
Interventions: Drug: CC100; Drug: Placebos
Sponsor: Chemigen, LLC
Recruiting - verified February 2017
Interventions: Drug: CC100; Drug: Placebos
Sponsor: Chemigen, LLC
Recruiting - verified February 2017
News Type: